Pharma Logistics Glossary: Clinical Trial
A clinical trial, also called a clinical study or a medical trial, is conducted to allow safety and efficacy data to be collected for health interventions (e.g., drugs, diagnostics, devices, therapy protocols). These trials can take place only after satisfactory information has been gathered on the quality of the non-clinical safety, and Health Authority/Ethics Committee approval is granted in the country where the trial is taking place. Depending on the type of product and the stage of its development, investigators enrol healthy volunteers and/or patients into small pilot studies initially, followed by larger scale studies in patients that often compare the new product with the currently prescribed treatment. As positive safety and efficacy data are gathered, the number of patients is typically increased. Clinical trials can vary in size from a single center in one country to multicenter trials in multiple countries.
Pharma Partnerships: Strengthen your links
June 06 by Pharma Logistics IQAt the 2018 Temperature Controlled Logistics conference we spoke with Dominic Hyde of Peli Biothermal.
IATA talks time on the tarmac with medicines
June 01 by Pharma LogisticsFrancisco Rizzuto of the International Air Transport Association (IATA) provides insight into they key mistakes made in lane mapping and time on the tarmac.
How Data Analytics Can Optimise the Performance of Clinical Trials
May 28 by Pharma LogisticsJoanne North Analytics Lead, Metrics, Reporting and Analytics, BioResearch Quality and Compliance - Johnson & Johnson.explores how data can propel today's clinical trials.
Wastage levels dip in clinical trial supply
February 20 by Pharma LogisticsClinical trial supply has seen a reduction in wastage rates thanks to smarter integration and alignment with enrollment rates from IVRS technology.
The Quest to Reduce Wastage In Clinical trials
January 26 by Pharma LogisticsIn meeting the growth ahead for clinical trials there must be a focus on efficiency as their supply suffers from major wastage issues.
Utilizing Clinical Research Organizations for late Phase I studies
February 23 by George Clinical RepresentativeA key step in developing a new drug is the transition from the laboratory to the human subject in a Phase I clinical trial, where the new compound is given to humans for the first time. A Phase I tria...
